Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
stromal vascular fraction cells
- Development stage
- Unknown
- Lead developer
- AdventHealth
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intralesional
01
Overview
Stromal vascular fraction (SVF) cells are an autologous, cell-based biologic therapy derived from a patient's own adipose tissue, currently being investigated by AdventHealth for the non-operative treatment of small partial-thickness rotator cuff tears. SVF is obtained via lipoaspiration and contains a heterogeneous population of cells, including adipose-derived mesenchymal stem cells (ADSCs), endothelial progenitor cells, and other regenerative cells. These cells are thought to promote tissue healing and regeneration of damaged tendons by secreting growth factors and differentiating into various cell types, such as tenocytes. In clinical studies (notably NCT05264922), the SVF cells are extracted, processed, and injected directly into the rotator cuff defect, often in combination with a biocompatible scaffold like fibrin glue (Tisseel) to ensure retention at the site of injury and combined with a structured exercise program.
- Other names
- SVF cellsautologous stromal vascular fraction cellsadipose-derived stromal vascular fraction cells
Beyond the preview
Go deeper on stromal vascular fraction cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on stromal vascular fraction cells.